Point72 »

Verve Therapeutics shares owned by Point72

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Point72 from 13F filings

Historical chart of Point72 investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Point72 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Point72

Quarter filed Position value Share count Share price at filing
2024-09-30 $83k 17k 4.84

More positions owned by Point72

Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Broadcom Call Option (AVGO)
Cisco Systems Call Option (CSCO)
Nike CL B Call Option (NKE)
Deere & Company Call Option (DE)
Adobe Systems Incorporated (ADBE)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Bristol Myers Squibb Call Option (BMY)
Accenture Plc Ireland Shs Class A Call Option (ACN)
NVIDIA Corporation Call Option (NVDA)
McKesson Corporation (MCK)
Bruker Corporation (BRKR)
General Motors Company (GM)

View all positions for Point72

Top funds holding Verve Therapeutics

Alphabet
BlackRock
BlackRock
Vanguard Group
Casdin Capital
State Street Corporation
T. Rowe Price Investment Management
Schonfeld Strategic Advisors
Novo A/S
Arch Venture Corp
Baker Bros. Advisors
Jpmorgan Chase & Co
Geode Capital Management
Jacobs Levy Equity Management
Redmile Group

View all funds holding Verve Therapeutics